The cytokine-induced inhibition of erythropoiesis is regarded as an important mechanism for the development of anemia in cancer patients, TNFα in particular but also other inflammatory regulators, including IL1β, IL6, IL10 and IFNγ, probably contribute [151,159]. This evidence concerns the gene IL1B and cancer.